BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 35345787)

  • 1. In situ Co-Delivery of Doxorubicin and Cisplatin by Injectable Thermosensitive Hydrogels for Enhanced Osteosarcoma Treatment.
    Si M; Xia Y; Cong M; Wang D; Hou Y; Ma H
    Int J Nanomedicine; 2022; 17():1309-1322. PubMed ID: 35345787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localized Co-delivery of Doxorubicin, Cisplatin, and Methotrexate by Thermosensitive Hydrogels for Enhanced Osteosarcoma Treatment.
    Ma H; He C; Cheng Y; Yang Z; Zang J; Liu J; Chen X
    ACS Appl Mater Interfaces; 2015 Dec; 7(49):27040-8. PubMed ID: 26575336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLK1shRNA and doxorubicin co-loaded thermosensitive PLGA-PEG-PLGA hydrogels for osteosarcoma treatment.
    Ma H; He C; Cheng Y; Li D; Gong Y; Liu J; Tian H; Chen X
    Biomaterials; 2014 Oct; 35(30):8723-34. PubMed ID: 25017095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal doxorubicin loaded PLGA-PEG-PLGA based thermogel for sustained local drug delivery for the treatment of breast cancer.
    Cao D; Zhang X; Akabar MD; Luo Y; Wu H; Ke X; Ci T
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):181-191. PubMed ID: 30686051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin and CD‑CUR inclusion complex co‑loaded in thermosensitive hydrogel PLGA‑PEG‑PLGA localized administration for osteosarcoma.
    Yang Z; Liu J; Lu Y
    Int J Oncol; 2020 Aug; 57(2):433-444. PubMed ID: 32468050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ subcutaneously injectable thermosensitive PEG-PLGA diblock and PLGA-PEG-PLGA triblock copolymer composite as sustained delivery of bispecific anti-CD3 scFv T-cell/anti-EGFR Fab Engager (BiTEE).
    Wei PS; Chen YJ; Lin SY; Chuang KH; Sheu MT; Ho HO
    Biomaterials; 2021 Nov; 278():121166. PubMed ID: 34634663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salinomycin-loaded injectable thermosensitive hydrogels for glioblastoma therapy.
    Norouzi M; Firouzi J; Sodeifi N; Ebrahimi M; Miller DW
    Int J Pharm; 2021 Apr; 598():120316. PubMed ID: 33540001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of PLGA-based hydrogel scaffold for improving the drug maximum-tolerated dose for in situ osteosarcoma treatment.
    Yang Z; Yu S; Li D; Gong Y; Zang J; Liu J; Chen X
    Colloids Surf B Biointerfaces; 2018 Dec; 172():387-394. PubMed ID: 30193198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of doxorubicin and (131)I by thermosensitive micellar-hydrogel for enhanced in situ synergetic chemoradiotherapy.
    Huang P; Zhang Y; Wang W; Zhou J; Sun Y; Liu J; Kong D; Liu J; Dong A
    J Control Release; 2015 Dec; 220(Pt A):456-464. PubMed ID: 26562684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.
    Gao B; Luo J; Liu Y; Su S; Fu S; Yang X; Li B
    Int J Nanomedicine; 2021; 16():4073-4085. PubMed ID: 34163160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermosensitive poly-(d,l-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(d,l-lactide-co-glycolide) hydrogels for multi-drug delivery.
    Cho H; Kwon GS
    J Drug Target; 2014 Aug; 22(7):669-77. PubMed ID: 24964052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injectable hydrogels for the sustained delivery of a HER2-targeted antibody for preventing local relapse of HER2+ breast cancer after breast-conserving surgery.
    Chen X; Wang M; Yang X; Wang Y; Yu L; Sun J; Ding J
    Theranostics; 2019; 9(21):6080-6098. PubMed ID: 31534538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localized controlled release of bevacizumab and doxorubicin by thermo-sensitive hydrogel for normalization of tumor vasculature and to enhance the efficacy of chemotherapy.
    Darge HF; Andrgie AT; Hanurry EY; Birhan YS; Mekonnen TW; Chou HY; Hsu WH; Lai JY; Lin SY; Tsai HC
    Int J Pharm; 2019 Dec; 572():118799. PubMed ID: 31678386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor microenvironment-labile polymer-doxorubicin conjugate thermogel combined with docetaxel for in situ synergistic chemotherapy of hepatoma.
    Zhang Y; Zhang J; Xu W; Xiao G; Ding J; Chen X
    Acta Biomater; 2018 Sep; 77():63-73. PubMed ID: 30006312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable thermosensitive black phosphorus nanosheet- and doxorubicin-loaded hydrogel for synergistic bone tumor photothermal-chemotherapy and osteogenesis enhancement.
    Li S; Qing Y; Lou Y; Li R; Wang H; Wang X; Ying B; Tang X; Qin Y
    Int J Biol Macromol; 2023 Jun; 239():124209. PubMed ID: 36972826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained release of bee venom peptide from biodegradable thermosensitive PLGA-PEG-PLGA triblock copolymer-based hydrogels in vitro.
    Qiao M; Chen D; Ma X; Hu H
    Pharmazie; 2006 Mar; 61(3):199-202. PubMed ID: 16599259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced photo/chemo combination efficiency against bladder tumor by encapsulation of DOX and ZnPC into in situ-formed thermosensitive polymer hydrogel.
    Huang Z; Xiao H; Lu X; Yan W; Ji Z
    Int J Nanomedicine; 2018; 13():7623-7631. PubMed ID: 30538447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CPPs-modified chitosan as permeability-enhancing chemotherapeutic combined with gene therapy nanosystem by thermosensitive hydrogel for the treatment of osteosarcoma.
    Cao J; Zhu C; Cao Z; Ke X
    Int J Biol Macromol; 2024 May; 267(Pt 2):130915. PubMed ID: 38561118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of metformin and levofloxacin hydrochloride using biodegradable thermosensitive hydrogel for the treatment of corneal neovascularization.
    Liu D; Wu Q; Zhu Y; Liu Y; Xie X; Li S; Lin H; Chen W; Zhu F
    Drug Deliv; 2019 Dec; 26(1):522-531. PubMed ID: 31090470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.